What does athersys do?
What does athersys do?
Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life.
What is multi stem cell therapy?
MultiStem® cell therapy is a patented regenerative medicine product candidate in clinical development that has shown the ability to promote tissue repair and healing in a variety of ways, such as through the production of therapeutic factors in response to signals of inflammation and tissue damage.
Where is athersys located?
Athersys has operations in Cleveland, Ohio and Leuven, Belgium.
Is athersys a good stock to buy?
Athersys has received a consensus rating of Buy.
Will stem cells cure everything?
Researchers hope stem cells will one day be effective in the treatment of many medical conditions and diseases. But unproven stem cell treatments can be unsafe—so get all of the facts if you’re considering any treatment. Stem cells have been called everything from cure-alls to miracle treatments.
How do doctors get stem cells?
The answer is simple: from the patient’s very own bone marrow or adipose (fat) tissue, depending on the procedure. For stem cell treatment for back, knee, shoulder or joint pain, adult stem cells are harvested from the patient’s own bone marrow.
How is multistem cell therapy off the shelf?
MultiStem cell therapy represents an “off-the-shelf” product candidate, meaning the cell suspension may be conveniently stored frozen in a vial. The vial can be quickly thawed and administered to a patient, typically through a simple intravenous infusion.
When to expand the use of multistem therapy?
After isolation from a qualified donor, the MultiStem product may be expanded on a large scale, unlike other cell types, for future clinical use and stored frozen until needed.
How are multistem cells stored in the body?
MultiStem cells are typically administered through a simple intravenous infusion. The cells are stored frozen in a vial until needed. The frozen suspension of cells in the vial is thawed when needed, the liquid cell suspension is removed from the vial using a sterile syringe and the cells are then added to an IV bag.
What are the intellectual property rights of Athersys?
Athersys has exclusive intellectual property rights to the MAPC technology that comprises the MultiStem product candidate. We have a broad intellectual property estate that covers our proprietary product candidates and technologies, as well as methods of production and methods of use.
